The Germany biotechnology market was valued at USD 38.94 Billion in 2025, driven by the strong public and private investment in biotech innovation and R&D, supported by well-established academic and research institutions across the region. The market is anticipated to grow at a CAGR of 10.30% during the forecast period of 2026-2035, with the values likely to reach USD 103.79 Billion by 2035. Favorable government initiatives and funding accelerate the development and commercialization of advanced biotechnological solutions. The market growth is also characterized by robust infrastructure, high R&D capacity, and a skilled workforce. Increasing adoption of precision medicine and biopharmaceuticals will support growth in the forecast period.
Base Year
Historical Period
Forecast Period
In October 2024, Evive Biotech and APOGEPHA launched Ryzneuta in Germany, marking its first overseas entry. This innovation is set to enhance treatment options and significantly drive biotechnology market growth in Germany.
Growing investments in pharmaceutical infrastructure are driving growth in the Germany biotechnology market. For instance, in September 2024, Exyte acquired TTP Group to expand high-tech biopharma facility capabilities and accelerate market growth.
The market is witnessing robust growth driven by strong R&D investment, favorable government policies, and innovation from domestic companies, significantly boosting advancements in healthcare, agriculture, and industrial biotech applications.
Compound Annual Growth Rate
10.3%
Value in USD Billion
2026-2035
*this image is indicative*
Biotechnology is the application of biological systems, organisms, or derivatives to develop or modify products and processes for specific use in healthcare, agriculture, and industry. It integrates molecular biology, genetics, and biochemistry disciplines to innovate solutions for global challenges. The biotechnology market in Germany demonstrates strong growth driven by advanced research infrastructure, government support, and increasing demand for biopharmaceuticals and diagnostics. The country is a key hub for European biotechnology innovation, with a high concentration of biotech companies and research institutions. The market was valued at USD 38.94 Billion in 2025.
Increasing Prevalence of Chronic Diseases to Elevate the Market Growth
The rising incidence of chronic and degenerative diseases remains a significant growth driver in the market. According to the World Health Organization 2021 data, ischemic heart disease led mortality rates, with 220.6 deaths per 100,000 males and 189.9 per 100,000 females. Other major causes include Alzheimer’s disease, stroke, cancers, chronic obstructive pulmonary disease, and kidney disorders. This persistent health burden has heightened the demand for innovative diagnostics, targeted therapies, and precision medicine, areas where biotechnology plays a pivotal role. As public and private sectors increase investment in research and development, the market is expected to grow steadily, supported by the urgent need for advanced healthcare solutions.
The market is experiencing trends such as rising investments and the emergence of innovative, sustainable technologies.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Technology
Market Breakup by Application
DNA Sequencing Poised to Revolutionize the Germany Biotechnology Market Growth
The biotechnology market in Germany encompasses diverse technologies, including nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others. Among these, DNA sequencing is expected to take the lead. The growth of this sector is driven by groundbreaking innovations like Merck’s Aptegra platform. Launched in April 2024, this next-generation sequencing technology streamlines biosafety testing by combining five assays into one, cutting testing time by 66% costs by 43%. As regulatory bodies increasingly embrace such efficient solutions, DNA sequencing stands at the forefront, reshaping biotech workflows and fueling the market’s future growth in Germany.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
QIAGEN N.V., established in 1984 and headquartered in Venlo, Netherlands, is a key player in the biotechnology market with a strong presence in Germany. In May 2025, QIAGEN enhanced its clinical genomics portfolio by acquiring Genoox, an AI-powered software company. This acquisition adds the Franklin platform, which offers advanced AI-driven genetic data interpretation, supporting clinical decision-making in genetic disorders and cancer treatments.
Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is a leading company in the biotechnology sector. In March 2025, it introduced sustainable large-capacity centrifuges, Cryofuge, BIOS, and LYNX, produced at its zero-waste facility in Osterode am Harz, Germany. These centrifuges enhance bioprocessing, blood banking, and research with improved energy efficiency and compliance with European environmental standards, reinforcing Thermo Fisher’s dedication to sustainable biotechnology.
Illumina Inc. is a global leader in DNA sequencing and genomic technologies. It was established in 1998 and is headquartered in San Diego, California. In May 2025, Illumina partnered with Ovation.io to launch the largest clinical multiomic GLP-1 dataset from 25,000 patients, accelerating the development of novel therapies and biomarkers in metabolic diseases. This initiative supports advancements in the biotechnology market.
Headquartered in Basel, Switzerland, and established in 1896, F. Hoffman-La Roche Ltd. is a leading biotechnology company. In January 2025, the company received FDA clearance for its highly sensitive VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay. This test aids in accurately diagnosing B-cell lymphoma, enhancing clinical decision-making and patient outcomes in hematopathology.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Evotec SE, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and BioNTech SE.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share